Shares of National Healthcare Properties, Inc. (NASDAQ:NHP – Get Free Report) have received an average recommendation of “Moderate Buy” from the ten research firms that are currently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $17.1250.
A number of analysts have weighed in on the company. Morgan Stanley assumed coverage on National Healthcare Properties in a research report on Monday, May 18th. They issued an “equal weight” rating and a $16.00 price target for the company. Wells Fargo & Company assumed coverage on National Healthcare Properties in a research report on Monday, May 18th. They issued an “overweight” rating and a $16.00 price target for the company. BMO Capital Markets assumed coverage on National Healthcare Properties in a research report on Monday, May 18th. They issued a “market perform” rating and a $17.00 price target for the company. The Goldman Sachs Group started coverage on National Healthcare Properties in a research report on Monday, May 18th. They issued a “buy” rating and a $20.00 price target for the company. Finally, Citigroup started coverage on National Healthcare Properties in a research report on Thursday, May 28th. They set an “outperform” rating for the company.
Check Out Our Latest Analysis on NHP
National Healthcare Properties Stock Down 2.2%
Read More
- Five stocks we like better than National Healthcare Properties
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for National Healthcare Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Healthcare Properties and related companies with MarketBeat.com's FREE daily email newsletter.
